Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare is on track to reach its 2029 targets of $25.00 of adjusted EPS and ~$64B of premium revenue with solid organic growth, operational and MCR improvement, and contribution from capital deployment (M&A, share repurchase). The company's focus on executing and maintaining market share, particularly in its core footprint, while also pursuing growth opportunities, is a key driver of its expected growth. With a strong track record of bringing acquisitions to target margins and a robust pipeline of potential targets, the company is well positioned for future growth. However, risks include potential deterioration in Medicaid margins, risk pool and membership mix issues, and changes in government policies.

Molina Healthcare is facing numerous challenges and risks that could negatively impact its financial performance in the near-term. These include continued mismatch between Medicaid rates and acuity, potential adverse risk pool changes in the Marketplace, and the potential impacts of eAPTCs. The company's lack of execution on operational initiatives and RFPs, as well as reimbursement and pricing pressure, could also hinder its success. Even if the company is able to overcome these challenges, there is still a risk from potential reimbursement cuts and cost trends remaining high. Despite a predicted improvement in margins and MLR, the assumption of persistently low rates and a potential acuity shift make us skeptical of the company's financial outlook.